These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 10866138)

  • 1. Study of tolbutamide-hydroxypropyl-gamma-cyclodextrin interaction in solution and solid state.
    Veiga MD; Ahsan F
    Chem Pharm Bull (Tokyo); 2000 Jun; 48(6):793-7. PubMed ID: 10866138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of griseofulvin with cyclodextrins in solid binary systems.
    Veiga MD; Díaz PJ; Ahsan F
    J Pharm Sci; 1998 Jul; 87(7):891-900. PubMed ID: 9649360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of surfactants (present in the dissolution media) on the release behaviour of tolbutamide from its inclusion complex with beta-cyclodextrin.
    Veiga MD; Ahsan F
    Eur J Pharm Sci; 2000 Jan; 9(3):291-9. PubMed ID: 10594387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of water solubility of sulfamethizole through its complexation with beta- and hydroxypropyl-beta-cyclodextrin. Characterization of the interaction in solution and in solid state.
    Pose-Vilarnovo B; Perdomo-López I; Echezarreta-López M; Schroth-Pardo P; Estrada E; Torres-Labandeira JJ
    Eur J Pharm Sci; 2001 Jun; 13(3):325-31. PubMed ID: 11384856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the preparation method on the physicochemical properties of tolbutamide/cyclodextrin binary systems.
    Veiga F; Fernandes C; Maincent P
    Drug Dev Ind Pharm; 2001 Jul; 27(6):523-32. PubMed ID: 11548859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complexation of the interferon inducer, bropirimine, with hydroxypropyl-beta-cyclodextrin.
    Echezarreta-López M; Torres-Labandeira JJ; Castiñeiras-Seijo L; Santana-Penín L; Vila-Jato JL
    Eur J Pharm Sci; 2000 Feb; 9(4):381-6. PubMed ID: 10664478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of ibuproxam complexation with amorphous beta-cyclodextrin derivatives in solution and in the solid state.
    Mura P; Zerrouk N; Faucci M; Maestrelli F; Chemtob C
    Eur J Pharm Biopharm; 2002 Sep; 54(2):181-91. PubMed ID: 12191690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complexation with tolbutamide modifies the physicochemical and tableting properties of hydroxypropyl-beta-cyclodextrin.
    Suihko E; Korhonen O; Järvinen T; Ketolainen J; Jarho P; Laine E; Paronen P
    Int J Pharm; 2001 Mar; 215(1-2):137-45. PubMed ID: 11250099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
    Srivalli KM; Mishra B
    AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid-state 13C nuclear magnetic resonance spectroscopic study on amorphous solid complexes of tolbutamide with 2-hydroxypropyl-alpha- and -beta-cyclodextrins.
    Kimura K; Hirayama F; Arima H; Uekama K
    Pharm Res; 1999 Nov; 16(11):1729-34. PubMed ID: 10571279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ternary systems of naproxen with hydroxypropyl-beta-cyclodextrin and aminoacids.
    Mura P; Maestrelli F; Cirri M
    Int J Pharm; 2003 Jul; 260(2):293-302. PubMed ID: 12842348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of an inclusion complex of cholesterol and hydroxypropyl-beta-cyclodextrin.
    Williams RO; Mahaguna V; Sriwongjanya M
    Eur J Pharm Biopharm; 1998 Nov; 46(3):355-60. PubMed ID: 9885309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complexation of zolpidem with 2-hydroxypropyl-beta-, methyl-beta-, and 2-hydroxypropyl-gamma-cyclodextrin: effect on aqueous solubility, dissolution rate, and ataxic activity in rat.
    Trapani G; Latrofa A; Franco M; Pantaleo MR; Sanna E; Massa F; Tuveri F; Liso G
    J Pharm Sci; 2000 Nov; 89(11):1443-51. PubMed ID: 11015689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.
    Dollo G; Le Corre P; Chollet M; Chevanne F; Bertault M; Burgot JL; Le Verge R
    J Pharm Sci; 1999 Sep; 88(9):889-95. PubMed ID: 10479350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of oxyphenbutazone with different cyclodextrins in aqueous medium and in the solid state.
    Veiga MD; Merino M
    J Pharm Biomed Anal; 2002 Jun; 28(5):973-82. PubMed ID: 12039640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ternary system of dihydroartemisinin with hydroxypropyl-β-cyclodextrin and lecithin: simultaneous enhancement of drug solubility and stability in aqueous solutions.
    Wang D; Li H; Gu J; Guo T; Yang S; Guo Z; Zhang X; Zhu W; Zhang J
    J Pharm Biomed Anal; 2013 Sep; 83():141-8. PubMed ID: 23732534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular modelling and 1H-NMR: ultimate tools for the investigation of tolbutamide: beta-cyclodextrin and tolbutamide: hydroxypropyl-beta-cyclodextrin complexes.
    Veiga FJ; Fernandes CM; Carvalho RA; Geraldes CF
    Chem Pharm Bull (Tokyo); 2001 Oct; 49(10):1251-6. PubMed ID: 11605649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The study on the preparation and spectroscopic properties of hydroxypropyl-beta-cyclodextrin/glipizide inclusion complex].
    Zhang YM; Li X; Sun CS; Chen CF
    Guang Pu Xue Yu Guang Pu Fen Xi; 2008 Mar; 28(3):711-4. PubMed ID: 18536450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the complexes of furosemide with 2-hydroxypropyl-beta-cyclodextrin and sulfobutyl ether-7-beta-cyclodextrin.
    Spamer E; Müller DG; Wessels PL; Venter JP
    Eur J Pharm Sci; 2002 Sep; 16(4-5):247-53. PubMed ID: 12208454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between lonidamine and beta- or hydroxypropyl-beta-cyclodextrin.
    Palmieri GF; Wehrlé P; Martelli S
    Drug Dev Ind Pharm; 1998 Jul; 24(7):653-60. PubMed ID: 9876510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.